The patient registry software market is expected to reach $2.1 billion by 2023, up from $868 million in 2014, based on a Transparency Market Research report, according to MedGadget.
Here are eight points:
1. The demand for accuracy and efficiency in patient database management will drive the patient registry software market.
2. The commercial registry software segment accounted for 83 percent of the overall market in 2014.
3. The public domain registry software segment is expected to experience a compound annual growth rate of 11.8 percent to 2023.
4. Diabetes registry dominated with a market share of 33 percent in 2014.
5. The commercial industry sector is expected to experience a compound annual growth rate of 10.7 percent to 2023.
6. North America dominated the market in 2014, with a market share of 45 percent. The increasing incidence of diabetes and chronic disease is driving the market.
7. Asia Pacific is expected to experience the fastest growth with a compound annual growth rate of 11.6 percent, due to an increasing number of disease registry pilot programs.
8. PatientCrossroads, Quintiles, Global Vision Technologies, Dacima Software and Evado eClinical Solutions lead the market.
